Cancer Awareness and Prevention Program

In 2025, it is projected that 29.8 million Indians will be suffering from cancer. Owing to its chronic nature and expensive treatment, out-of-pocket expenditure is the highest for cancer. In India, insurance coverage is limited and health expenditures are not covered for 80% of the population. 

One in 10 Indians will develop cancer during their lifetime and one in 15 Indians will die of cancer, says the World Cancer Report released by the World Health Organisation which has pointed out “socioeconomic inequalities” as a major cause for the rapidly increasing burden of the disease in the country. The five most frequent cancers in India between men and women are breast, cervical, oral, lung, and colorectal. These top five account for 47.2 per cent of all cancers and they can be prevented, screened for and/or detected early 0and treated at an early stage. 60% of cancer in India are either tobacco-related or due to infection i.e. HVP, Hepatitis c etc. Over 70% of cases were reported in an advanced stage of the disease, resulting in poor survival. The only way to win the battle against cancer is through Awareness, Prevention & Early Detection. Up to 40% of all cancers can be prevented by avoiding tobacco and adopting other healthy habits. Regular screening helps detect many cancers in their early stages when they can be treated successfully.

Rajiv Gandhi Cancer Institute & Research Centre is amongst Asia’s premier exclusive cancer centers that offer the unique advantage of cutting-edge technology, put to use by renowned super-specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighbouring SAARC countries. We are fortunate to have taken care of over 3 Lakh patients since our inception in 1996.

The Institute offers super-specialized tertiary care services in Medical, Surgical and Radiation Oncology by dedicated Site-Specific teams. Super Specialists at RGCI&RC practice an organ-specific multi-disciplinary approach to cancer diagnosis and treatment, with the Tumor Board acting as a second opinion clinic for cases that are more critical than others.

Spread over nearly 2 lakh square feet of area, with a current capacity of 498 beds, RGCI&RC is one of the largest tertiary cancer care centres in the continent. The Institute’s outpatient services are spread over all 4 building blocks with 57 consultation rooms and well-designed Radiation Therapy areas. RGCI&RC has 14 state-of-the-art well equipped modular Operation Theatres with HEPA filter and gas scavenging systems, and 3 Minor Operation Theatres for Day Care Surgeries and procedures. The Institute has40 bedded Surgical ICU and a 12 bedded Medical ICU. RGCI&RC has a dedicated Leukemia ward, and a separate Thyroid Ward. The Institute also boasts of an independent21 bedded Bone Marrow Transplant unit that is credited with pioneering unrelated donor transplants, MUD transplants, and stem cell transplants.

RGCI&RC is committed to bringing the benefits of cutting-edge technology to its patients. The Institute offers best-in-class techniques such as robotic surgery, Intra-Operative Brachytherapy, True Beam (the next generation Image Guided Radiation Therapy), PET – MRI fusion, High-Frequency Ultrasound, Tomosynthesis ( 3D mammography machine), Nucleic Acid Testing (for safest possible blood), and advanced diagnostic & imaging techniques, including PET CT, Circulating Tumor Cell testing, and Next Generation Sequencing. RGCI&RC has executed strategic alliances with internationally renowned institutes which have catapulted RGCI&RC into a global league of select hospitals that are pioneers in new approaches to treating cancer.

RGCI&RC has consistently ranked amongst the Best Oncology Hospitals of India (Week – Nielsen Survey 2014, 2015, 2016) and has won prestigious awards for its services, such as Best Oncology Hospital in India (2014), Healthcare Leader Award (2014), and India’s Most Trusted Cancer Hospital (2016).

RGCIRC is a comprehensive state-of-the-art cancer hospital with all facilities from prevention to palliation available under one roof. The latest technologies will be used by RGCIRC to diagnose and treat the disease if a person is found to have cancer during the screening program in this adopted underserved population.